Vancomycin-resistant Staphylococcus aureus primary prevention: Difference between revisions
Hardik Patel (talk | contribs) (Created page with "__NOTOC__ {{Vancomycin-resistant Staphylococcus aureus}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to lear...") |
Hardik Patel (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Use of appropriate infection control practices (such as wearing gloves before and after contact with infectious body substances and adherence to hand hygiene) by healthcare personnel can reduce the spread of VISA and VRSA. | Use of appropriate infection control practices (such as wearing gloves before and after contact with infectious body substances and adherence to hand hygiene) by healthcare personnel can reduce the spread of VISA and VRSA. Because VISA and VRSA are only part of the larger problem of antimicrobial resistance in healthcare settings, CDC has started a campaign to prevent antimicrobial resistance. The campaign centers around four strategies that clinicians can use to prevent antimicrobial resistance, which include prevention of [[infection]]s, effective diagnosis and treatment of [[infection]]s, wise use of antimicrobials, and prevention of transmission. A series of evidence-based steps are described that can reduce the development and spread of resistant organisms such as VISA and VRSA. | ||
==References== | ==References== | ||
Revision as of 16:09, 17 December 2012
|
Vancomycin-resistant Staphylococcus aureus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant Staphylococcus aureus primary prevention On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus primary prevention |
|
FDA on Vancomycin-resistant Staphylococcus aureus primary prevention |
|
CDC on Vancomycin-resistant Staphylococcus aureus primary prevention |
|
Vancomycin-resistant Staphylococcus aureus primary prevention in the news |
|
Blogs on Vancomycin-resistant Staphylococcus aureus primary prevention |
|
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
|
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Use of appropriate infection control practices (such as wearing gloves before and after contact with infectious body substances and adherence to hand hygiene) by healthcare personnel can reduce the spread of VISA and VRSA. Because VISA and VRSA are only part of the larger problem of antimicrobial resistance in healthcare settings, CDC has started a campaign to prevent antimicrobial resistance. The campaign centers around four strategies that clinicians can use to prevent antimicrobial resistance, which include prevention of infections, effective diagnosis and treatment of infections, wise use of antimicrobials, and prevention of transmission. A series of evidence-based steps are described that can reduce the development and spread of resistant organisms such as VISA and VRSA.